药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Amifostine
Ivosidenib
The serum concentration of Romidepsin can be increased when it is combined with Ivosidenib.
Amifostine
Etravirine
The serum concentration of Romidepsin can be decreased when it is combined with Etravirine.
Amifostine
Isavuconazonium
The serum concentration of Romidepsin can be increased when it is combined with Isavuconazonium.
Amifostine
Isavuconazole
The serum concentration of Romidepsin can be increased when it is combined with Isavuconazole.
Amifostine
Pitolisant
The serum concentration of Romidepsin can be decreased when it is combined with Pitolisant.
Amifostine
Delamanid
Romidepsin may increase the QTc-prolonging activities of Delamanid.
Amifostine
Apalutamide
The serum concentration of Romidepsin can be decreased when it is combined with Apalutamide.
Amifostine
Vemurafenib
The serum concentration of Romidepsin can be increased when it is combined with Vemurafenib.
Amifostine
Eliglustat
The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Eliglustat.
Amifostine
Terodiline
The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Terodiline.
Amifostine
Macimorelin
The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Macimorelin.
Amifostine
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Deutetrabenazine.
Amifostine
Ivabradine
The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Ivabradine.
Amifostine
Artemether
The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Artemether.
Amifostine
Asenapine
The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Asenapine.
Amifostine
Iloperidone
The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Romidepsin.
Amifostine
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Romidepsin.
Amifostine
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Romidepsin.
Amifostine
Temafloxacin
The risk or severity of QTc prolongation can be increased when Temafloxacin is combined with Romidepsin.
Amifostine
Lithium cation
The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Romidepsin.